Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash Flow
All numbers in thousandsBreakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-892,869
-892,869
-2,104,929
-1,830,047
-126,609
Depreciation & amortization
71,554
71,554
44,423
29,076
13,864
Deferred income taxes
-801
-801
-14,609
0
0
Stock based compensation
229,884
229,884
1,930,641
1,606,020
476
Change in working capital
29,837
29,837
-37,006
-61,537
-26,515
Accounts receivable
50,068
50,068
55,024
-114,094
-14,228
Inventory
-
-
164
-626
-2,736
Accounts Payable
-1,183
-1,183
-10,844
-2,247
7,019
Other working capital
-336,301
-336,301
-304,469
-310,339
-193,651
Other non-cash items
49,853
49,853
-12,603
-20,947
-1,061
Net cash provided by operating activites
-295,500
-295,500
-252,198
-253,818
-135,830
Cash flows from investing activities
Investments in property, plant and equipment
-40,801
-40,801
-52,271
-56,521
-57,821
Acquisitions, net
-42,980
-42,980
-55,721
-12,040
0
Purchases of investments
0
0
-3,691
-5,000
0
Other investing activites
-1,340
-1,340
-38,078
304
-9,300
Net cash used for investing activites
-80,693
-80,693
-67,394
-73,257
-67,121
Cash flows from financing activities
Debt repayment
-1,295
-1,295
-1,237
-1,123
-748
Common stock issued
0
0
99,303
0
0
Common stock repurchased
0
0
0
-24,998
0
Other financing activites
-2,014
-2,014
-2,969
1,560,099
-
Net cash used privided by (used for) financing activities
-3,216
-3,216
95,337
1,534,145
90,318
Net change in cash
-379,997
-379,997
-223,347
1,207,051
-112,633
Cash at beginning of period
1,369,581
1,369,581
1,592,928
385,877
498,510
Cash at end of period
989,584
989,584
1,369,581
1,592,928
385,877
Free Cash Flow
Operating Cash Flow
-295,500
-295,500
-252,198
-253,818
-135,830
Capital Expenditure
-40,801
-40,801
-52,271
-56,521
-57,821
Free Cash Flow
-336,301
-336,301
-304,469
-310,339
-193,651
© 2024 Yahoo. All rights reserved.